Jeffrey S Farrow Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey S Farrow.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey S Farrow. Jeffrey S Farrow is V.P., Finance and CAO in RENOVIS INC ($RNVS) and CFO in HYPERION THERAPEUTICS INC ($HPTX) and Chief Financial Officer in ZS Pharma, Inc. ($ZSPH) and Chief Financial Officer in Global Blood Therapeutics, Inc. ($GBT).
Latest Insider Trading Transactions of Jeffrey S Farrow
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GBT, HPTX, RNVS, ZSPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 03 2021 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,020 | 0 | 18,120 | |
| Feb 03 2021 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 12,500 | |
| Feb 03 2021 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,875 | 0 | 5,750 | |
| Feb 03 2021 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,063 | 0 | 0 | |
| Feb 03 2021 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 49.49 | 5,865 | 290,259 | 15,402 | 21.3 K to 15.4 K (-27.58 %) |
| Feb 03 2021 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 12,083 | 0 | 21,267 | 9.2 K to 21.3 K (+131.57 %) |
| Aug 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,020 | 0 | 21,140 | |
| Aug 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 15,625 | |
| Aug 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,020 | 0 | 21,140 | |
| Aug 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,875 | 0 | 8,625 | |
| Aug 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 15,625 | |
| Aug 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,062 | 0 | 3,063 | |
| Aug 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,875 | 0 | 8,625 | |
| Aug 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 67.48 | 5,946 | 401,236 | 9,184 | 15.1 K to 9.2 K (-39.30 %) |
| Aug 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,062 | 0 | 3,063 | |
| Aug 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 12,082 | 0 | 15,130 | 3 K to 15.1 K (+396.39 %) |
| Aug 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 67.48 | 5,946 | 401,236 | 9,184 | 15.1 K to 9.2 K (-39.30 %) |
| Aug 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 12,082 | 0 | 15,130 | 3 K to 15.1 K (+396.39 %) |
| Jul 15 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Sell | S | 75.00 | 15,208 | 1,140,600 | 3,048 | 18.3 K to 3 K (-83.30 %) |
| Jun 11 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Sell | S | 67.00 | 15,208 | 1,018,936 | 18,256 | 33.5 K to 18.3 K (-45.45 %) |
| Jun 03 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | A | 0.00 | 42,400 | 0 | 42,400 | |
| Feb 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | A | 65.82 | 38,500 | 2,534,070 | 38,500 | |
| Feb 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | A | 0.00 | 24,160 | 0 | 24,160 | |
| Feb 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 18,750 | |
| Feb 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,875 | 0 | 11,500 | |
| Feb 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,063 | 0 | 6,125 | |
| Feb 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 65.26 | 4,398 | 287,013 | 33,464 | 37.9 K to 33.5 K (-11.62 %) |
| Feb 04 2020 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 9,063 | 0 | 37,862 | 28.8 K to 37.9 K (+31.47 %) |
| Dec 17 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
| Dec 17 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 76.88 | 2,479 | 190,586 | 28,799 | 31.3 K to 28.8 K (-7.93 %) |
| Dec 17 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 5,000 | 0 | 31,278 | 26.3 K to 31.3 K (+19.03 %) |
| Aug 05 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 21,875 | |
| Aug 05 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,875 | 0 | 14,375 | |
| Aug 05 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,062 | 0 | 9,188 | |
| Aug 05 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 54.25 | 3,421 | 185,589 | 26,278 | 29.7 K to 26.3 K (-11.52 %) |
| Aug 05 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 9,062 | 0 | 29,699 | 20.6 K to 29.7 K (+43.91 %) |
| Apr 10 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,000 | 0 | 5,000 | |
| Apr 10 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 58.51 | 692 | 40,489 | 20,637 | 21.3 K to 20.6 K (-3.24 %) |
| Apr 10 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 2,000 | 0 | 21,329 | 19.3 K to 21.3 K (+10.35 %) |
| Feb 05 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,875 | 0 | 17,250 | |
| Feb 05 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,063 | 0 | 12,250 | |
| Feb 05 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 05 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | A | 48.44 | 40,000 | 1,937,600 | 40,000 | |
| Feb 05 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 48.44 | 2,164 | 104,824 | 19,329 | 21.5 K to 19.3 K (-10.07 %) |
| Feb 05 2019 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 5,938 | 0 | 21,493 | 15.6 K to 21.5 K (+38.17 %) |
| Nov 28 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 16.40 | 3,048 | 49,987 | 33,952 | |
| Nov 28 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 16.40 | 3,048 | 49,987 | 15,555 | 12.5 K to 15.6 K (+24.37 %) |
| Aug 03 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,875 | 0 | 20,125 | |
| Aug 03 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,062 | 0 | 15,313 | |
| Aug 03 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 43.15 | 2,400 | 103,560 | 12,507 | 14.9 K to 12.5 K (-16.10 %) |
| Aug 03 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 5,937 | 0 | 14,907 | 9 K to 14.9 K (+66.19 %) |
| Feb 16 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,000 | 0 | 7,000 | |
| Feb 16 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 62.30 | 692 | 43,112 | 8,970 | 9.7 K to 9 K (-7.16 %) |
| Feb 16 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 2,000 | 0 | 9,662 | 7.7 K to 9.7 K (+26.10 %) |
| Feb 02 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | A | 0.00 | 23,000 | 0 | 23,000 | |
| Feb 02 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | A | 59.60 | 35,000 | 2,086,000 | 35,000 | |
| Feb 02 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,063 | 0 | 18,375 | |
| Feb 02 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,000 | 0 | 9,000 | |
| Feb 02 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 59.60 | 1,060 | 63,176 | 7,662 | 8.7 K to 7.7 K (-12.15 %) |
| Feb 02 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 3,063 | 0 | 8,722 | 5.7 K to 8.7 K (+54.13 %) |
| Feb 02 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 57.90 | 692 | 40,067 | 5,659 | 6.4 K to 5.7 K (-10.90 %) |
| Feb 02 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 2,000 | 0 | 6,351 | 4.4 K to 6.4 K (+45.97 %) |
| Jan 26 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,000 | 0 | 11,000 | |
| Jan 26 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 58.15 | 683 | 39,716 | 4,351 | 5 K to 4.4 K (-13.57 %) |
| Jan 26 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 2,000 | 0 | 5,034 | 3 K to 5 K (+65.92 %) |
| Jan 18 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,000 | 0 | 13,000 | |
| Jan 18 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 52.10 | 877 | 45,692 | 3,034 | 3.9 K to 3 K (-22.42 %) |
| Jan 18 2018 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 2,000 | 0 | 3,911 | 1.9 K to 3.9 K (+104.66 %) |
| Aug 14 2017 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Aug 03 2017 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,062 | 0 | 21,438 | |
| Aug 03 2017 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Payment of Exercise | F | 25.10 | 1,151 | 28,890 | 1,911 | 3.1 K to 1.9 K (-37.59 %) |
| Aug 03 2017 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Buy | M | 0.00 | 3,062 | 0 | 3,062 | 0 to 3.1 K |
| Jan 19 2017 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | A | 16.40 | 37,000 | 606,800 | 37,000 | |
| Jan 19 2017 | GBT | Global Blood Thera ... | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | A | 0.00 | 24,500 | 0 | 24,500 | |
| Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | D | 56.31 | 77,900 | 4,386,549 | 0 | |
| Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | D | 56.31 | 7,100 | 399,801 | 0 | |
| May 08 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Option Exercise | D | 25.97 | 32,500 | 844,025 | 0 | |
| May 08 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Option Exercise | D | 26.74 | 38,000 | 1,016,120 | 0 | |
| May 08 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Option Exercise | D | 24.46 | 39,500 | 966,170 | 0 | |
| May 08 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Option Exercise | D | 10.95 | 14,371 | 157,362 | 0 | |
| May 08 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Option Exercise | D | 7.31 | 23,346 | 170,659 | 0 | |
| May 08 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Sell | D | 46.00 | 120,777 | 5,555,742 | 0 | 120.8 K to 0 (-100.00 %) |
| May 08 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Sell | D | 46.00 | 22,687 | 1,043,602 | 0 | 22.7 K to 0 (-100.00 %) |
| May 08 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Sell | U | 46.00 | 878 | 40,388 | 0 | 878 to 0 (-100.00 %) |
| May 05 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Option Exercise | M | 10.95 | 629 | 6,888 | 14,371 | |
| May 05 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Option Exercise | M | 7.31 | 17,704 | 129,416 | 23,346 | |
| May 05 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Option Exercise | M | 4.08 | 53,184 | 216,991 | 0 | |
| May 05 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Option Exercise | M | 1.28 | 24,630 | 31,526 | 0 | |
| May 05 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Option Exercise | M | 1.28 | 24,630 | 31,526 | 0 | |
| May 05 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Buy | M | 10.95 | 629 | 6,888 | 144,402 | 143.8 K to 144.4 K (+0.44 %) |
| May 05 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Buy | M | 7.31 | 17,704 | 129,416 | 143,773 | 126.1 K to 143.8 K (+14.04 %) |
| May 05 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Buy | M | 4.08 | 53,184 | 216,991 | 126,069 | 72.9 K to 126.1 K (+72.97 %) |
| May 05 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Buy | M | 1.28 | 24,630 | 31,526 | 72,885 | 48.3 K to 72.9 K (+51.04 %) |
| May 05 2015 | HPTX | HYPERION THERAPEUT ... | Farrow Jeffrey S | CFO | Buy | M | 1.28 | 24,630 | 31,526 | 48,255 | 23.6 K to 48.3 K (+104.25 %) |
| May 06 2008 | RNVS | RENOVIS INC | Farrow Jeffrey S | V.P., Finance and C ... | Option Exercise | D | 2.62 | 756 | 1,981 | 0 | |
| May 06 2008 | RNVS | RENOVIS INC | Farrow Jeffrey S | V.P., Finance and C ... | Option Exercise | D | 2.62 | 25,494 | 66,794 | 0 | |
| May 06 2008 | RNVS | RENOVIS INC | Farrow Jeffrey S | V.P., Finance and C ... | Option Exercise | D | 5.40 | 1,698 | 9,169 | 0 | |
| May 06 2008 | RNVS | RENOVIS INC | Farrow Jeffrey S | V.P., Finance and C ... | Option Exercise | D | 5.40 | 15,523 | 83,824 | 0 | |
| May 06 2008 | RNVS | RENOVIS INC | Farrow Jeffrey S | V.P., Finance and C ... | Sell | D | 0.00 | 62,286 | 0 | 0 | 62.3 K to 0 (-100.00 %) |
| Feb 12 2008 | RNVS | RENOVIS INC | Farrow Jeffrey S | V.P., Finance and C ... | Payment of Exercise | F | 2.40 | 4,987 | 11,969 | 62,286 | 67.3 K to 62.3 K (-7.41 %) |
| Feb 04 2008 | RNVS | RENOVIS INC | Farrow Jeffrey S | V.P., Finance and C ... | Option Exercise | A | 2.62 | 26,250 | 68,775 | 26,250 | |
| Jul 02 2007 | RNVS | RENOVIS INC | Farrow Jeffrey S | V.P., Finance and C ... | Grant | A | 0.00 | 10,000 | 0 | 66,666 | 56.7 K to 66.7 K (+17.65 %) |
Page: 1